Nobuichi Kuribayashi
Overview
Explore the profile of Nobuichi Kuribayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Koshizaka M, Ishikawa K, Ishikawa T, Kobayashi K, Takemoto M, Horikoshi T, et al.
BMJ Open
. 2017 May;
7(5):e015766.
PMID: 28490565
Introduction: In Japan, dipeptidyl peptidase-4 (DPP-4) inhibitors are frequently used as the treatment of choice for patients with type 2 diabetes. In some cases, however, poor glycaemic and body weight...
22.
Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, et al.
Diabetes Care
. 2017 Apr;
40(6):808.
PMID: 28420699
No abstract available.
23.
Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, et al.
Diabetes Care
. 2017 Apr;
40(6):808.
PMID: 28420697
No abstract available.
24.
Mita T, Katakami N, Shiraiwa T, Yoshii H, Kuribayashi N, Osonoi T, et al.
Sci Rep
. 2017 Jan;
7:39965.
PMID: 28067320
The effect of hypoglycemia on the progression of atherosclerosis in patients with type 2 diabetes mellitus (T2DM) remains largely unknown. This is a post hoc analysis of a randomized trial...
25.
Kanatsuka A, Sato Y, Kawai K, Hirao K, Kobayashi M, Kashiwagi A, et al.
J Diabetes Investig
. 2016 Jun;
7(3):386-95.
PMID: 27330726
Aims/introduction: We carried out an observational cohort study to examine the relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetics. Materials And Methods: We...
26.
Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, et al.
Diabetes Care
. 2016 Jan;
39(3):455-64.
PMID: 26822324
Objective: The effect of additional treatment with oral hypoglycemic agents on the progression of atherosclerosis remains unknown in insulin-treated patients with type 2 diabetes mellitus (T2DM). We assessed the effects...
27.
Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, et al.
Diabetes Care
. 2015 Dec;
39(1):139-48.
PMID: 26628419
Objective: Recent experimental studies have shown that dipeptidyl peptidase 4 (DPP-4) inhibitors have antiatherosclerotic benefits in glucagon-like peptide 1-dependent and -independent manners. The current study investigated the effects of alogliptin,...
28.
Sakane N, Kotani K, Tsuzaki K, Nishi M, Takahashi K, Murata T, et al.
J Diabetes Investig
. 2015 Sep;
6(5):567-70.
PMID: 26417415
The aim of the present study was to investigate the prevalence of fear of hypoglycemia, in association with severe hypoglycemia and social factors, in insulin-treated patients with type 2 diabetes...
29.
Yokoh H, Kobayashi K, Sato Y, Takemoto M, Uchida D, Kanatsuka A, et al.
J Diabetes Investig
. 2015 Mar;
6(2):182-91.
PMID: 25802726
Aims/introduction: To assess the efficacy and safety of sitagliptin compared with α-glucosidase inhibitors in Japanese patients with type 2 diabetes inadequately controlled by metformin or pioglitazone alone. Materials And Methods:...
30.
Kudo C, Shin W, Minabe M, Harai K, Kato K, Seino H, et al.
Odontology
. 2014 Aug;
103(3):314-21.
PMID: 25119713
It has been revealed that atherosclerosis and periodontal disease may have a common mechanism of "chronic inflammation". Several reports have indicated that periodontal infection is related to atherosclerosis, but none...